Yusop, Aga A.
HRN: 01-58-68 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/06/2022
CEFUROXIME 1.5GM (VIAL)
06/06/2022
06/12/2022
IV
1.5g
Q8h
Abnormal Uterine Bleeding; T/C UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary TractReproductive Tract Compliance to guidelines: Guideline Not Available
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes